Peptide Stack for Bodybuilding: CJC-1295, Ipamorelin, IGF-1 LR3, and MGF

Peptides have become a serious tool in the bodybuilder's toolkit — not as shortcuts, but as targeted support for the biological processes that drive muscle growth, recovery, and body composition. Unlike anabolic steroids, peptide stacks work primarily through growth hormone pulse amplification, local muscle repair signaling, and insulin-like growth factor pathways.

This guide covers a well-researched bodybuilding peptide stack built around CJC-1295, ipamorelin, IGF-1 LR3, and MGF, including training-timed protocols, post-workout windows, and what the evidence actually supports.

Why Peptides for Bodybuilding?

The primary goal in bodybuilding is maximizing muscle protein synthesis while minimizing catabolism and fat accumulation. Growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormones (GHRHs) work synergistically to amplify natural GH pulses, which downstream elevate IGF-1 and support lean mass accrual.

The advantage over exogenous HGH is that these peptides stimulate your own pituitary to release GH, preserving the natural pulsatile rhythm that matters for receptor sensitivity. Research published in the Journal of Clinical Endocrinology & Metabolism shows that maintaining pulsatile GH release is important for anabolic signaling without desensitization.

The Core Bodybuilding Peptide Stack

Layer 1: CJC-1295 + Ipamorelin (Foundation)

This is the backbone of most evidence-based GH-focused stacks. CJC-1295 (without DAC) is a GHRH analog that amplifies each GH pulse, while ipamorelin is a selective GHRP that triggers GH release without significantly raising cortisol or prolactin — a key advantage over older GHRPs like GHRP-2 or GHRP-6.

Protocol:

• CJC-1295 (no DAC): 100–150 mcg
• Ipamorelin: 100–200 mcg
• Timing: 30–45 minutes before bed, and optionally 30 minutes pre-workout
• Administration: Subcutaneous injection
• Cycle: 12–16 weeks on, 4–8 weeks off

These two peptides stack synergistically. CJC-1295 primes the pituitary, and ipamorelin triggers the release — the combination produces GH pulses 2–5x greater than either compound alone, according to research in growth hormone axis pharmacology.

For more on this combination, see our guide to CJC-1295 and ipamorelin individually.

Layer 2: IGF-1 LR3 (Hypertrophy Amplification)

Insulin-like growth factor-1 Long R3 (IGF-1 LR3) is a modified form of IGF-1 with a longer half-life (~20 hours versus ~15 minutes for native IGF-1). IGF-1 LR3 acts directly on muscle cells to promote protein synthesis, hyperplasia, and satellite cell activation — the same satellite cells responsible for adding new muscle nuclei.

Protocol:

• Dose: 20–50 mcg per day
• Timing: Post-workout, injected into the trained muscle group (intramuscular or subcutaneous near the site)
• Duration: 4–6 weeks maximum, then a 4-week washout period
• Cycle note: Use IGF-1 LR3 in periodic blocks, not continuously

The localized injection approach is supported by research showing that IGF-1 acts as a local autocrine/paracrine factor in skeletal muscle, not just a systemic hormone. Post-workout timing capitalizes on the anabolic window when muscle fibers are actively undergoing repair.

Caution: IGF-1 LR3 is potent. Start at 20 mcg and assess tolerance. Hypoglycemia is a real risk — always use with a meal or carbohydrate source nearby.

Layer 3: MGF (Mechano Growth Factor)

Mechano Growth Factor is a splice variant of IGF-1 produced locally in muscle in response to mechanical loading (i.e., weight training). Its primary role is activating quiescent muscle stem cells (satellite cells) so they can proliferate and donate nuclei to damaged fibers.

Protocol:

• Dose: 200–400 mcg, 2–3x per week
• Timing: Immediately post-workout (within 30 minutes), injected into the trained muscle group
• Cycle: Use in 4–6 week blocks during peak hypertrophy phases

MGF has a very short half-life in serum (~minutes), which is why the post-workout injection window matters. PEGylated MGF (PEG-MGF) extends the half-life significantly, which may be more practical if daily pinning is not desired.

Training Timing Protocol

Optimizing peptide timing around training maximizes the anabolic signal:

Morning training days:

• Pre-workout (30 min before): CJC-1295 + ipamorelin (skip breakfast for 2+ hours before for maximum GH response)
• Post-workout (within 30 min): IGF-1 LR3 + MGF at trained site
• Before bed: CJC-1295 + ipamorelin (second dose)

Rest days:

• Morning (fasted): CJC-1295 + ipamorelin
• Before bed: CJC-1295 + ipamorelin

The fasted state matters because elevated blood glucose and insulin blunt GH release. Injecting GHRPs and GHRHs on an empty stomach produces significantly larger GH pulses.

Post-Workout Recovery Window

The 30–60 minutes following training represents the highest muscle sensitivity to anabolic signals. Muscle fiber tears trigger local IGF-1 and MGF production, and exogenous MGF and IGF-1 LR3 amplify that native response.

For recovery between sessions, BPC-157 and TB-500 can be added to the stack for connective tissue support — particularly valuable for bodybuilders training at high frequency or intensity.

Stacking with Nutrition and Training

Peptides are not a substitute for fundamentals. This stack performs best when combined with:

• Protein intake: 1.6–2.2 g/kg/day to support protein synthesis signaling
• Caloric surplus: 250–500 kcal above maintenance during bulking phases
• Training stimulus: Progressive overload remains the primary driver; peptides amplify the response
• Sleep: GH secretion is highest during slow-wave sleep — 7–9 hours supports both natural GH pulses and the additional CJC/ipamorelin-driven release

Expected Results and Timeline

Weeks 1–4: Improved sleep quality, better recovery between sessions, mild reduction in body fat. Muscle fullness often improves due to increased glycogen storage.

Weeks 4–8: More noticeable lean mass accrual, improved joint and connective tissue integrity, reduction in delayed-onset muscle soreness.

Weeks 8–16: Cumulative lean tissue gains of 5–12 lbs are reported by experienced users, though individual response varies significantly based on training, nutrition, and baseline hormone levels.

Safety and Monitoring

This stack is generally well-tolerated when used at research doses. Key considerations:

• Get baseline IGF-1 blood levels before starting; recheck at 6–8 weeks
• Monitor fasting glucose, especially when using IGF-1 LR3
• Avoid use if you have a history of cancer or have family history of hormone-sensitive cancers (IGF-1 is a growth factor)
• Cycle responsibly — continuous use without breaks can downregulate pituitary receptors

Review how to reconstitute peptides before beginning any injectable protocol.

Frequently Asked Questions

Q: Can I use this stack as a beginner? Beginners typically see excellent results from training and nutrition alone. If you are going to use peptides, start with just CJC-1295 and ipamorelin before adding IGF-1 LR3 and MGF. Build your baseline before layering complexity.

Q: Do I need to cycle off? Yes. CJC-1295 + ipamorelin should be cycled 12–16 weeks on, 4–8 weeks off. IGF-1 LR3 should be used in 4–6 week blocks with equal washout periods. Continuous use risks receptor desensitization and may suppress endogenous IGF-1 production.

Q: Is this stack legal? These peptides are not approved for human use by the FDA and are classified as research chemicals in most jurisdictions. They are prohibited by WADA for competitive athletes. See our guide on peptides and the WADA banned list for specifics.

Q: Can I use this stack while cutting? Yes — this stack can be used during a caloric deficit. GH and IGF-1 have lipolytic properties that support fat loss while preserving lean mass. Lower your IGF-1 LR3 dose to 20 mcg during a cut to avoid hypoglycemia risk.

Q: How does this compare to anabolic steroids? Peptide stacks produce milder but more sustainable results with a significantly lower side effect profile. They do not suppress the HPTA (hypothalamic-pituitary-testicular axis) the way anabolic steroids do, and recovery after cycling is straightforward. For a full comparison, see peptides vs. steroids.